ALLMedicine™ Diabetic Neuropathy Center

May 13th, 2022 - Diabetic Neuropathy: In Search of a Treatment.|2022|Yorek MA,|drug therapy,

Apr 22nd, 2022 - Schwann cell necroptosis in diabetic neuropathy.|2022|Belavgeni A,Maremonti F,Stadtmüller M,Bornstein SR,Linkermann A,|

Apr 17th, 2022 - Neuropathy is one of the most important complications of diabetes. According to recent advances, vitamin D deficiency might play a role in the development and progression of diabetic neuropathy. Moreover, therapeutic vitamin D supplementation has ...

Apr 14th, 2022 - This retrospective cohort study describes the utilization of opioids and gabapentin among patients with diabetic neuropathy who were gabapentin and opioid naïve, and assesses predictors of concomitant use of opioids and gabapentin. Using Medicare ...

Apr 12th, 2022 - Gabapentinoids, which include gabapentin and pregabalin, are antiepileptic drugs that have been approved by the FDA and Health Canada for the treatment of postherpetic neuralgia, with pregabalin also approved for the treatment of diabetic neuropat...

Aug 18th, 2021 - Diabetic Neuropathy.|2021|Ziegler D,Keller J,Maier C,Pannek J,|diagnosis,epidemiology,etiology,therapy,standards,methods,organization & administration,standards,epidemiology,methods,standards,methods,standards,

Jun 23rd, 2011 - The Cardiovascular Autonomic Neuropathy (CAN) Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy worked to update CAN guidelines, with regard to epidemiology, clinical impact, diagnosis, usefulness of CAN testing, and management. C...

Apr 13th, 2011 - To develop a scientifically sound and clinically relevant evidence-based guideline for the treatment of painful diabetic neuropathy (PDN). We performed a systematic review of the literature from 1960 to August 2008 and classified the studies accor...

Apr 12th, 2022 - Gabapentinoids, which include gabapentin and pregabalin, are antiepileptic drugs that have been approved by the FDA and Health Canada for the treatment of postherpetic neuralgia, with pregabalin also approved for the treatment of diabetic neuropat...

Apr 12th, 2022 - Diabetic neuropathy is the most common complication associated with diabetes mellitus, affecting approximately 50-70% of patients with diabetes. The prevalence of pain and of paraesthesia were 20% and 33% 10 years after diagnosis of diabetes melli...

Apr 11th, 2022 - The symptoms of chronic constipation are defined as infrequent bowel movements, hard stool, straining during defecation, bloating, abdominal discomfort, and sensation of incomplete evacuation. Constipation has been reported as a common complicatio...

Mar 24th, 2022 - Current data estimated that 451 million people, (age 18-99 years) suffered from diabetes world wide in 2017, and are expected to rise to 693 million by 2045. Among them, type 2 diabetes mellitus (T2DM) accounts for around 90% of all cases with dia...

Mar 17th, 2022 - Magnesium (MgSO4) is a N-Methyl-D-aspartate (NMDA) receptor antagonist and is thought to be involved in the modulation of pain. There has been little direct evidence that MgSO4 relieve neuropathic pain and prevents opioid-induced hyperalgesia in h...

May 17th, 2022 - New 18-month data for a 10-kHz implanted spinal cord stimulation device (Nevro) shows continued relief of painful diabetic neuropathy symptoms in patients refractory to conventional medical therapy. The 10-kHz device, called HFX, involves minimall...

May 12th, 2022 - In March, I shared a case of a woman with diabetes-related peripheral neuropathy to highlight issues of pain management in primary care. To recap: Maria, age 68, had been experiencing burning pain sensations in her feet and ankles for the past 3 y...

Mar 24th, 2022 - To focus on issues of pain management in primary care, I'll put before you a clinical scenario involving a woman with diabetes-related peripheral neuropathy. I'll tell you what I plan to do, but I'm most interested in crowdsourcing a response from...

Jan 4th, 2022 - Updated guidelines from the American Academy of Neurology (AAN) advise against prescribing opioids for painful diabetic neuropathy (PDN) — but note that several other oral and topical therapies may help ease pain. PDN is very common and can greatl...

Dec 30th, 2021 - Gabapentinoids, serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, and sodium channel blockers were more likely than placebo to improve diabetic neuropathy pain, according to a new practice guideline from the American...